Return to homepagePandemic Pact

Harnessing universal immunity to influenza

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA58835

Grant search

Key facts

  • Disease

    Unspecified

  • Start & end year

    2020
    2024

  • Known Financial Commitments (USD)

    $1,730,837.39

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adolescent (13 years to 17 years)Children (1 year to 12 years)Infants (1 month to 1 year)Newborns (birth to 1 month)Older adults (65 and older)

  • Vulnerable Population

    Indigenous PeopleWomen

  • Occupations of Interest

    Unspecified

Abstract

Prof Kedzierska's work combines cutting-edge basic research with unique clinical studies to define how to generate protective immunity against the pandemic and newly emerged influenza viruses. This research will identify key factors that drive the severe and fatal influenza disease in high-risk groups, including the young, elderly, pregnant women and Indigenous Australians. Findings on the optimal human immunity to influenza viruses will be applicable to other infectious diseases and tumours.